David Abrams - Abrams Capital Management 13F Activity & Position Changes (Q3 2022)

As of Sep 30, 2022, the Abrams Capital Management portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Nov 10, 2022. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q3 2022, the filing reported:

New Buys - None reported

Increases - Alphabet Inc.

Reductions - Coupang, Inc., Energy Transfer LP, Kinder Morgan, Inc., Teva Pharmaceutical Industries , USCB Financial Holdings, Inc.

Complete Exits - None reported

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q3 2022	CPNG Coupang, Inc.	Coupang, Inc.	Sell	-208,045	-1.5%	$223.29K	13,395,026
Q3 2022	ET Energy Transfer LP	Energy Transfer LP	Sell	-105,000	-0.5%	$242.87K	22,019,322
Q3 2022	GOOGL Alphabet Inc.	Alphabet Inc.	Buy	+2,764,160	+1887.6%	$278.40K	2,910,600
Q3 2022	KMI Kinder Morgan, Inc.	Kinder Morgan, Inc.	Sell	-9,098,512	-72.9%	$56.20K	3,377,688
Q3 2022	TEVA Teva Pharmaceutical Industries	Teva Pharmaceutical Industries	Sell	-147,060	-0.6%	$192.87K	23,899,296
Q3 2022	USCB USCB Financial Holdings, Inc.	USCB Financial Holdings, Inc.	Sell	-13,960	-1.6%	$11.08K	845,394